市场调查报告书
商品编码
1138403
全球血管内动脉瘤修復市场-2022-2029Global Endovascular Aneurysm Repair Market - 2022-2029 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
腹主动脉瘤血管内治疗的创新技术有望推动市场增长。
已经提出了一种基于聚合物的技术来通过血管内方法治疗 AAA。正在为临床目的开发两种不同的基于聚合物的平台。用于周向密封动脉瘤的聚合物装置已被证明是安全有效的。此外,通过将 O 形环与主动脉壁相适配,这种基于聚合物的平台提供了对动脉瘤的定制密封,并且可以在不影响颈部扩张的情况下保持稳定多年。我可以做到。使用聚合物通道而不是织物支撑的传统金属支架框架使此类平台变薄,有可能扩大患者对微创 EVAR 治疗的适用性。这种技术的影响已经很大。因此,利用聚合物的特性定制和封闭动脉瘤的可能性代表了 EVAR 手术的一次重大革命。因此,上述声明预计将在预测期内推动市场。
与开放式手术相比,EVAR 手术的支架瞬时动脉瘤和充血性心力衰竭的风险、不良的报销政策以及扩张成本。这些是预计在预测期内阻碍市场的一些因素。
COVID-19 大流行对医疗保健系统和市场产生了适度影响。大流行包括执行的心血管手术数量显着下降,包括腹主动脉瘤 (AAA) 修復。例如,对 COVID-19 传播的担忧导致英国大部分地区在封锁期间暂停 AAA 筛查(包括监测),并且(由于 NHS 内的能力下降)存在手术干预延迟的风险。正在考虑缓解。此外,破裂的AAA死亡率高,需要进行AAA筛查。每年约有 300,000 名男性接受筛查,其中约 1% 被发现患有 AAA,但仍有约 15,000 名男性未经检测。因此,预计市场在预测期内将活跃。
行业分析
血管内动脉瘤修復市场根据各种行业因素(包括未满足的需求、定价分析、供应链分析和监管分析)对市场进行深入分析。
全球血管内动脉瘤修復市场报告提供大约 45 多个市场数据表、40 多个图表和 180 页内容。
Endovascular Aneurysm Repair market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 4.6% during the forecast period (2022-2029).
An aortic aneurysm is a condition in which the aorta becomes enlarged. Abdominal pain, low blood pressure, loss of consciousness, and even death can result from these diseases. Endovascular aneurysm repair (EVAR) is a minimally invasive surgical procedure that can treat abdominal and thoracic aortic aneurysms. It is a less invasive and less time-consuming alternative to open surgery for abdominal aortic aneurysms (AAA).
Innovative technologies in the endovascular treatment of abdominal aortic aneurysms are expected to drive market growth.
Polymer-based technology has been proposed for treating AAA with an endovascular approach. Two different polymer-based platforms have been developed for clinical purposes. The polymer device to create a circumferential sealing of the aneurysm has proven safe and effective. Moreover, adapting the O-ring to the aortic wall, this polymer-based platform offers a customized sealing of the aneurysm, which remains stable over the years without influencing neck dilatation. The low profile of such a platform based on polymer channels rather than traditional metallic stent frames to support the fabric may expand patient applicability for a minimally invasive EVAR treatment. The impact of this kind of technology is already significant. Therefore, the possibility of using polymer characteristics to create a customized sealing of the aneurysm has been a great revolution in EVAR procedures. Thus, the market is expected to drive in the forecast period from the above statements.
The stent moment leads to the risk of an aneurysm and congestive heart failure, insufficient reimbursement policies, and the inflated cost of EVAR procedures compared to open surgeries. These are some of the factors that the market is expected to get hampered in the forecast period.
The COVID-19 pandemic has moderately impacted healthcare systems and the market. The pandemic included a substantial reduction in the number of cardiovascular procedures performed, including repair of Abdominal Aortic Aneurysms (AAA). For instance, AAA screening (including surveillance) in most areas of the UK was paused during the lockdown due to concerns about COVID-19 transmission and while strategies are considered regarding mitigating risk from delayed surgical intervention (as a result of reduced capacity within the NHS). Moreover, ruptured AAA carries a high mortality and screening for AAA. Circa 300,000 men are offered screening annually, of whom around 1% are found to have an AAA, while approximately 15,000 men are yet to tests. Thus, the market will undergo impetus during the forecast period.
Industry Analysis
The endovascular aneurysm repair market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.
The adjunctive stent graft segment is expected to hold the largest market share in the endovascular aneurysm repair market.
The adjunctive stent-graft segment accounted for the largest market share in 2021. Adjunctive stenting significantly reduces the risk of postoperative stent-graft limb occlusion without obvious compromise to the aneurysm repair. Endovascular grafting is a minimally invasive method to treat an aortic aneurysm. Through minor incisions in the groin, a stent graft (a fabric tube supported by metal wire stents that support the weak area in the aorta) is placed into the aneurysm. Endovascular aneurysm treatment does not require a major incision and has a significantly quicker recovery than traditional open surgery. Therefore, it increased the demand for adjunctive stent graft, due to which the market is expected to hold the largest market share in the forecast period.
North American region is expected to hold the largest market share in the global endovascular aneurysm repair market.
North America accounted for the highest revenue share in 2021. The increasing prevalence of aneurysms and the rising geriatric population are more prone to this condition, due to which the market is expected to boost in the forecast period. For instance, Aortic aneurysms have an incidence of 5-10 cases per 100,000 in the United States and are more common in men over 60. Though aortic aneurysms do not directly cause death, complications arising from an aneurysm - such as dissection or rupture - cause approximately 15,000 deaths annually. AA primarily affects elderly males in the sixth and seventh decades of life with tobacco use, hypertension and atherosclerosis risk factors. For AAA, individuals with first-degree family members with the disease are at two-fold risk of developing AAA compared to patients with no family history. Moreover, according to the Population Reference Bureau report, the number of Americans aged 65 and up is expected to double by 2060, from 46 million to nearly 98 million. Therefore, it increases the demand for AAA treatments such as EVAR, due to which the North American region is expected to hold the largest market share in the forecast period.
Major key players in the endovascular aneurysm repair market are Cardinal Health, Lombard Medical Limited, Endologix Inc., Terumo Corporation, MicroPort Scientific Corporation, JOTEC GmbH, W. L. Gore & Associates, Inc., Cook Group Incorporated and Medtronic plc.
Medtronic plc is an American-Irish registered medical device company primarily operating in the United States. It has an operational and executive headquarters in Fridley, Minnesota, in the US. Moreover, it develops and manufactures devices and therapies to treat more than 30 chronic diseases, including heart failure, Parkinson's disease, urinary incontinence, Down syndrome, obesity, chronic pain, spinal disorders and diabetes. It is operated in 140 countries and employs over 104,950 people.
Heli-FX EndoAnchor system: The Heli-FX EndoAnchor system is intended to provide fixation and sealing between endovascular aortic grafts and the native artery.
The global endovascular aneurysm repair market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.